Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Knezović, Ana and Lončar, Anamarija and Homolak, Jan and Smailović, Una and Osmanović Barilar, Jelena and Ganoci, Lana and Božina, Nada and Riederer, Peter and Šalković-Petrišić, Melita (2017) Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease? Journal of Neural Transmission, 124 (6). pp. 695-708. ISSN 0300-9564

[img] PDF - Accepted Version
Download (1MB)

Abstract

Accumulated evidence suggests that the insulin-resistant brain state and cerebral glucose hypometabolism might be the cause, rather than the consequence, of the neurodegeneration found in a sporadic Alzheimer's disease (sAD). We have explored whether the insulin receptor (IR) and the glucose transporter-2 (GLUT2), used here as their markers, are the early targets of intracerebroventricularly (icv) administered streptozotocin (STZ) in an STZ-icv rat model of sAD, and whether their changes are associated with the STZ-induced neuroinflammation. The expression of IR, GLUT2 and glial fibrillary acidic protein (GFAP) was measured by immunofluorescence and western blot analysis in the parietal (PC) and the temporal (TC) cortex, in the hippocampus (HPC) and the hypothalamus. One hour after the STZ-icv administration (1.5 mg/kg), the GFAP immunoreactivity was significantly increased in all four regions, thus indicating the wide spread neuroinflammation, pronounced in the PC and the HPC. Changes in the GLUT2 (increment) and the IR (decrement) expression were mild in the areas close to the site of the STZ injection/release but pronounced in the ependymal lining cells of the third ventricle, thus indicating the possible metabolic implications. These results, together with the finding of the GLUT2-IR co-expression, and also the neuronal IR expression in PC, TC and HPC, indicate that the cerebral GLUT2 and IR should be further explored as the possible sAD etiopathogenic factors. It should be further clarified whether their alterations are the effect of a direct STZ-icv toxicity or they are triggered in a response to STZ-icv induced neuroinflammation.

Item Type: Article
MeSH: Alzheimer Disease/metabolism ; Animals ; Brain/metabolism ; Disease Models, Animal ; Glial Fibrillary Acidic Protein/metabolism ; Glucose Transporter Type 2/metabolism ; Inflammation/metabolism ; Male ; Neuroglia/metabolism ; Neuroimmunomodulation/physiology ; Rats, Wistar ; Receptor, Insulin/metabolism ; Risk Factors ; Streptozocin ; Time Factors
Departments: Katedra za farmakologiju
Depositing User: Martina Žužak
Status: Published
Creators:
CreatorsEmail
Knezović, AnaUNSPECIFIED
Lončar, AnamarijaUNSPECIFIED
Homolak, JanUNSPECIFIED
Smailović, UnaUNSPECIFIED
Osmanović Barilar, JelenaUNSPECIFIED
Ganoci, LanaUNSPECIFIED
Božina, NadaUNSPECIFIED
Riederer, PeterUNSPECIFIED
Šalković-Petrišić, MelitaUNSPECIFIED
Date: June 2017
Date Deposited: 23 Sep 2019 07:21
Last Modified: 20 Aug 2020 06:54
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/2862

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year